Emma Bernard
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Antimicrobial Resistance in Staphylococcus 7
- Co-authors
- P. Dellamonica (34 shared papers)R. Garraffo (12 shared papers)P Lapalus (6 shared papers)Éric Cua (7 shared papers)Céline Pulcini (8 shared papers)H Drugeon (2 shared papers)V. Mondain (10 shared papers)Jacques Durant (10 shared papers)
In The Last Decade
Emma Bernard
47 papers receiving 556 citations
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 42
- Molecular Medicine 85
- Pharmacology 195
- Clinical Biochemistry 62
- Infectious Diseases 166
Countries citing papers authored by Emma Bernard
This map shows the geographic impact of Emma Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Bernard more than expected).
Fields of papers citing papers by Emma Bernard
This network shows the impact of papers produced by Emma Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Bernard. The network helps show where Emma Bernard may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 68 | |
| 2 | 1990 | 66 | |
| 3 | 2008 | 48 | |
| 4 | 1986 | 45 | |
| 5 | 1989 | 36 | |
| 6 | 2011 | 28 | |
| 7 | 2013 | 23 | |
| 8 | 1990 | 17 | |
| 9 | 1988 | 15 | |
| 10 | 2015 | 14 | |
| 11 | 1994 | 14 | |
| 12 | 1993 | 14 | |
| 13 | 2014 | 14 | |
| 14 | 1994 | 13 | |
| 15 | Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. | 1992 | 13 |
| 16 | 2003 | 12 | |
| 17 | 2012 | 12 | |
| 18 | 1998 | 12 | |
| 19 | [Necrotizing fasciitis of the eyelids and orbit: a life-threatening ophthalmological emergency]. | 2002 | 12 |
| 20 | 2017 | 12 |
About Emma Bernard
Emma Bernard is a scholar working on Pharmacology, Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine and Surgery, having authored 50 papers that have together received 600 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Orthopedic Infections and Treatments (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Infectious Diseases and Tuberculosis (5 papers), Streptococcal Infections and Treatments (5 papers), Antibiotic Resistance in Bacteria (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (42 citations), Molecular Medicine (85 citations), Pharmacology (195 citations), Clinical Biochemistry (62 citations) and Infectious Diseases (166 citations). Emma Bernard has collaborated with scholars based in France, Germany and Vietnam. Frequent co-authors include P. Dellamonica, R. Garraffo, P Lapalus, Éric Cua, Céline Pulcini, H Drugeon, V. Mondain, Jacques Durant, Jean–Jacques Garaud and J. L. Vildé. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Drugs, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.